Join
Live feed
·
PRReleasevia Quantisnow
Allogene Therapeutics Inc. logo

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update

ByQuantisnow·Wall Street's wire, on your screen.
ALLO· Allogene Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALLO (Allogene Therapeutics Inc.) and more on Quantisnow.